Bernstein Raises agilon health Price Target to $138
Bullish analyst view, though a price target alone is limited evidence.
Public signal · 1-minute delayed
Source-backed market context you can read and share without an account.
Bullish analyst view, though a price target alone is limited evidence.
What happened, with direct paths to the underlying reporting
Bernstein raised its price target for AGL to $138, versus the posted price of $90.53, implying substantial target upside. This is an analyst opinion, not a guarantee of performance.
Target: $138
Posted price: $90.53
Analyst firm: Bernstein
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.